Henoch Schonlein purpura in pediatric patients with inflammatory bowel disease: A case series.

Autor: Sheth AP; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Vivar KL; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.; Department of Dermatology, Ann & Robert H Lurie Children's Hospital of Chicago, Chicago, Illinois, USA., Wagner AM; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.; Department of Dermatology, Ann & Robert H Lurie Children's Hospital of Chicago, Chicago, Illinois, USA., Kruse LL; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.; Department of Dermatology, Ann & Robert H Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
Jazyk: angličtina
Zdroj: Pediatric dermatology [Pediatr Dermatol] 2021 Sep; Vol. 38 (5), pp. 1389-1392. Date of Electronic Publication: 2021 Sep 24.
DOI: 10.1111/pde.14818
Abstrakt: Retrospective chart review was conducted to identify the clinical features of Henoch Schonlein purpura (HSP) in five children with inflammatory bowel disease (IBD). All five children, four of which were on anti-TNF therapies, experienced the onset of HSP after their IBD diagnosis. HSP averaged 20.8 months in duration. The patients in our cohort, particularly those on anti-TNF therapy for inflammatory bowel disease, experienced chronic and recurrent courses of HSP.
(© 2021 Wiley Periodicals LLC.)
Databáze: MEDLINE
Externí odkaz: